BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  Viking Therapeutics to Participate in Upcoming Investor Conferences - Aug. 28, 2019

  Viking Therapeutics, Inc. announced that the company will participate in two upcoming investor conferences.

  August 28, 2019

   · 

  2 min read
• Biotech Bay

  50 Companies Select Veeva Vault CTMS to Modernize Clinical Trial Management

  Vault CTMS unifies end-to-end clinical information and processes for greater visibility throughout the trial lifecycle

  August 28, 2019

   · 

  3 min read
• Drug Development

  Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

  Arrowhead earns $25 million milestone payment in connection with trial initiation

  August 28, 2019

   · 

  4 min read
• Job Trends

  Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology

  Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first FDA (510k) cleared magnesium-based bone void filler in the orthopedic marketplace, designed to assist with bone repair and regeneration

  August 28, 2019

   · 

  4 min read
• Drug Development

  IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results

  IRLAB announced that the in-depth analysis of the data from the recently concluded Phase IIa study of IRL790 in Parkinson’s patients with L-dopa induced dyskinesia brings further evidence of the drug candidate’s ability to significantly and meaningfully improve daytime movement quality.

  August 28, 2019

   · 

  6 min read
• Genetown

  Alexion to Present at the 14th Annual Citi Biotech Conference

  Alexion Pharmaceuticals announced that management will present at the 14th Annual Citi Biotech Conference in Boston, MA on Wednesday, September 4th, 2019 at 12:00 p.m., ET.

  August 28, 2019

   · 

  1 min read
• Business

  NCSBN inducts 13th group of Fellows of the NCSBN Institute of Regulatory Excellence (IRE)

  The National Council of State Boards of Nursing, www.ncsbn.org, inducted its 13th group of Fellows of the NCSBN Institute of Regulatory Excellence during the NCSBN Annual Meeting and Delegate Assembly, held in Chicago, Aug. 21-23, 2019.

  August 28, 2019

   · 

  2 min read
• Deals

  Syndax Announces Participation at Four Upcoming Investor Conferences - Aug. 28, 2019

  Syndax Pharmaceuticals, Inc. announced that members of the management team will participate in four upcoming investor conferences.

  August 28, 2019

   · 

  2 min read
• Biotech Beach

  Ionis Pharmaceuticals to present at upcoming investor conferences - Aug. 28, 2019

  Ionis Pharmaceuticals, Inc., the leader in antisense therapeutics, announced that management will present a company overview at the following investor conferences

  August 28, 2019

   · 

  1 min read
• Deals

  Aimmune to Participate in Three Investor Conferences in September - Aug. 28, 2019

  Aimmune Therapeutics, Inc. announced that members of the Aimmune executive management team will participate in three upcoming investor conferences in September

  August 28, 2019

   · 

  2 min read